APA (7th ed.) Citation

Bruglia, M., Cardini, F., Di Luzio, R., Fiorini, S., Guberti, A., Haddoub, S., . . . Di Bartolo, P. (2025). Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus. Diabetes Therapy, 16(8), 1707. https://doi.org/10.1007/s13300-025-01762-3

Chicago Style (17th ed.) Citation

Bruglia, Matteo, et al. "Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus." Diabetes Therapy 16, no. 8 (2025): 1707. https://doi.org/10.1007/s13300-025-01762-3.

MLA (9th ed.) Citation

Bruglia, Matteo, et al. "Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus." Diabetes Therapy, vol. 16, no. 8, 2025, p. 1707, https://doi.org/10.1007/s13300-025-01762-3.